TXG
10x Genomics, Inc.
+6.61 (+9.10%)79.30USD1.5M成交股數10.3B市值–本益比(近四季)16.7股價營收比-12.7%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 151M-13% | 151M-3% | 166M+9% | 149M-3% | 173M+23% | 155M-16% | 152M-1% | 153M+4% | 141M | 184M | 154M | 147M |
| 營業成本 | 38.5M | 44.7M | 53.0M | 48.7M | 47.8M | 49.4M | 45.3M | 48.9M | 48.1M | 68.2M | 58.1M | 47.2M |
| 毛利 | 112M-10% | 106M+1% | 113M+6% | 100M-4% | 125M+35% | 105M-9% | 106M+11% | 104M+5% | 92.9M | 116M | 95.5M | 99.6M |
| 毛利率 | 74.5% | 70.4% | 68.1% | 67.3% | 72.3% | 68.1% | 70.2% | 68.1% | 65.9% | 62.9% | 62.2% | 67.8% |
| 研發費用 | 56.8M | 56.8M | 56.0M | 57.2M | 61.2M | 64.2M | 66.2M | 62.9M | 68.6M | 65.3M | 66.5M | 71.5M |
| 銷售管理費用 | 78.7M | 66.4M | 76.6M | 75.4M | 74.4M | 89.7M | 81.7M | 83.0M | 85.8M | 86.1M | 82.4M | 91.5M |
| 營業利益 | −19.6M-165% | −17.0M-57% | −19.5M-53% | −32.2M-23% | 30.1M-149% | −39.3M-29% | −41.5M-56% | −41.7M-34% | −61.5M | −55.2M | −94.8M | −63.4M |
| 營業利益率 | -12.9% | -11.3% | -11.8% | -21.6% | 17.4% | -25.4% | -27.4% | -27.3% | -43.6% | -30.0% | -61.7% | -43.2% |
| 稅後淨利 | −17.9M-152% | −13.5M-61% | −16.2M-55% | −27.5M-28% | 34.5M-158% | −34.4M-30% | −35.8M-62% | −37.9M-39% | −59.9M | −49.0M | −93.0M | −62.4M |
| 淨利率 | -11.9% | -8.9% | -9.8% | -18.4% | 20.0% | -22.2% | -23.6% | -24.8% | -42.5% | -26.6% | -60.5% | -42.5% |
| 稀釋 EPS | -0.14-150% | -0.10-64% | -0.13-57% | -0.22-31% | 0.28-156% | -0.28-33% | -0.30-62% | -0.32-40% | -0.50 | -0.42 | -0.79 | -0.53 |
| 稀釋股數 | 130M | 128M | 125M | 126M | 125M | 123M | 121M | 120M | 119M | 117M | 118M | 117M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 503M | 490M | 474M | 433M | 398M | 377M | 398M | 380M | 356M | 359M | 315M | 331M |
| 應收帳款 | 47.5M | 39.0M | 47.0M | 43.8M | 50.0M | 52.5M | 83.5M | 91.2M | 91.3M | 115M | 104M | 87.7M |
| 存貨 | 52.6M | 53.5M | 56.3M | 62.0M | 69.0M | 74.7M | 94.1M | 88.3M | 83.2M | 73.7M | 80.9M | 83.7M |
| 總資產 | 1.0B | 1.0B | 1.0B | 1.0B | 980M | 903M | 938M | 930M | 923M | 965M | 949M | 990M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 205M | 201M | 245M | 242M | 207M | 196M | 215M | 206M | 204M | 224M | 203M | 196M |
| 股東權益 | 826M | 814M | 796M | 785M | 773M | 707M | 723M | 724M | 719M | 741M | 745M | 793M |
| 負債比 | 19.9% | 19.8% | 23.5% | 23.6% | 21.1% | 21.8% | 22.9% | 22.1% | 22.1% | 23.2% | 21.4% | 19.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 26.1M-24% | – | – | – | 34.4M | – | – | −15.7M | – | – | – |
| 資本支出 | – | 1.6M | – | – | – | 1.9M | – | – | 2.9M | – | – | – |
| 自由現金流 | – | 24.5M-24% | – | – | – | 32.5M | – | – | −18.6M | – | – | – |
| 折舊攤銷 | – | 10.0M | – | – | – | 8.0M | – | – | 9.2M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 16.3% | – | – | – | 21.0% | – | – | -13.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 643M
| 美國 | 347M | 53.9% | +3.6% |
|---|---|---|---|
| 歐洲中東非洲 | 162M | 25.2% | +1.2% |
| 中國 | 70.3M | 10.9% | +22.6% |
| Asia Pacific Excluding China | 52.1M | 8.1% | +13.3% |
| Americas Excluding United States | 12.3M | 1.9% | -8.8% |
| 美洲 小計 | 359M | 55.8% | +3.2% |
| 亞太 小計 | 122M | 19.0% | +18.5% |
產品／服務2025 年度 · 643M
| Single Cell Consumables | 363M | 56.5% | -2.4% |
|---|---|---|---|
| Spatial Consumables | 144M | 22.4% | +18.9% |
| Licensing And Royalty Revenue | 46.1M | 7.2% | +14272.3% |
| Spatial Instruments | 34.1M | 5.3% | -40.7% |
| 服務 | 32.7M | 5.1% | +34.6% |
| Single Cell Instruments | 22.7M | 3.5% | -35.6% |
| Product And Service Revenue 小計 | 597M | 92.8% | -2.3% |
| Consumables 小計 | 507M | 78.9% | +2.8% |
| Instruments 小計 | 56.8M | 8.8% | -38.8% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 643M | +5.2% | −43.5M | -6.8% | -0.35 | 130M |
| FY2024 | 611M | -1.3% | −183M | -29.9% | -1.52 | −5.7M |
| FY2023 | 619M | +19.8% | −255M | -41.2% | -2.18 | −63.8M |
| FY2022 | 516M | +5.3% | −166M | -32.1% | -1.46 | −165M |
| FY2021 | 490M | +64.1% | −58.2M | -11.9% | -0.53 | −123M |
| FY2020 | 299M | +21.5% | −543M | -181.6% | -5.37 | −255M |
| FY2019 | 246M | +68.1% | −31.3M | -12.7% | -0.80 | −8.1M |
| FY2018 | 146M | – | −112M | -76.9% | -8.40 | −82.7M |